Search research articles
Contact Us
Filters
Showing results (121-130 of 129) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 129 results.
Progress in Clinical and Biological Research
|
January 1, 1990
Effect of prostaglandin E1 and (the NO-donor) isosorbidedinitrate on thromboresistance in human in-vivo
H Sinzinger, P Fitscha, F Rauscha, et al.
Lancet (London, England)
|
March 17, 1990
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease
H Sinzinger, P Fitscha, J O'Grady, et al.
Eicosanoids
|
January 1, 1991
13,14-dihydro-PGE1, an in-vivo metabolite of PGE1, decreases mitotic activity induced by corticosteroid administration
P Fitscha, F Rauscha, W Rogatti, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1993
Increase in in vivo low-density lipoprotein (LDL) receptor binding after PGE1 and 13,14-dihydro-PGE1 treatment in rabbits
H Sinzinger, I Virgolini, S R Li, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1991
Isradipine, a calcium-entry blocker, decreases vascular [125-I]low-density lipoprotein entry in hypercholesterolemic rabbits
H Sinzinger, G Lupattelli, I Virgolini, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Vascular uptake of 111-In-platelets and of 123-I-LDL
G Lupattelli, I Virgolini, P Fitscha, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Studies on pharmacokinetics, platelet function and fibrinolytic activity under various prostaglandin E1 infusion regimens
T Simmet, P Fitscha, B A Peskar, et al.
Wiener Klinische Wochenschrift
|
July 15, 1988
[Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease]
P Fitscha, T Simmet, B A Peskar, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1991
A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy
W Klein, V Mitrovic, H Neuss, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 129) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 129 results.
Progress in Clinical and Biological Research
|
January 1, 1990
Effect of prostaglandin E1 and (the NO-donor) isosorbidedinitrate on thromboresistance in human in-vivo
H Sinzinger, P Fitscha, F Rauscha, et al.
Lancet (London, England)
|
March 17, 1990
Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease
H Sinzinger, P Fitscha, J O'Grady, et al.
Eicosanoids
|
January 1, 1991
13,14-dihydro-PGE1, an in-vivo metabolite of PGE1, decreases mitotic activity induced by corticosteroid administration
P Fitscha, F Rauscha, W Rogatti, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1993
Increase in in vivo low-density lipoprotein (LDL) receptor binding after PGE1 and 13,14-dihydro-PGE1 treatment in rabbits
H Sinzinger, I Virgolini, S R Li, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1991
Isradipine, a calcium-entry blocker, decreases vascular [125-I]low-density lipoprotein entry in hypercholesterolemic rabbits
H Sinzinger, G Lupattelli, I Virgolini, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
Vascular uptake of 111-In-platelets and of 123-I-LDL
G Lupattelli, I Virgolini, P Fitscha, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Studies on pharmacokinetics, platelet function and fibrinolytic activity under various prostaglandin E1 infusion regimens
T Simmet, P Fitscha, B A Peskar, et al.
Wiener Klinische Wochenschrift
|
July 15, 1988
[Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease]
P Fitscha, T Simmet, B A Peskar, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1991
A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy
W Klein, V Mitrovic, H Neuss, et al.
Page
of 13